This past March, the U.S. Food & Drug Administration (FDA) approved aprocitentan for use in conjunction with other antihypertensive drugs in adults whose blood pressure is not adequately controlled with other medicatons.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
